ABSTRACT
The extent of adverse health effects, including induction/exacerbation of infectious lung disease, arising from entrainment of equivalent amounts (or exposure to a fixed increment) of fine particulate matter (PM2.5) can vary from region to region or city to city in a region. To begin to explain how differing effects on host resistance might arise after exposure to PM2.5 from various sites, we hypothesized that select metals (e.g., V, Al, and Mn) in each PM2.5 caused changes in alveolar macrophage (AM) Fe status that, ultimately, would lead to altered antibacterial function. To test this, iron-response protein (IRP) binding activity in a rat AM cell line was assessed after exposure to Fe alone and in conjunction with V, Mn, and/or Al at ratios of V:Fe, Al:Fe, or Mn:Fe encountered in PM2.5 samples from New York City, Los Angeles, and Seattle. Results indicated that V and Al each significantly altered IRP activity, though effects were not consistently ratio-(i.e., dose-) dependent; Mn had little impact on activity. We conclude that the reductions in Fe status detected here via the IRP assay arose, in part, from effects on transferrin-mediated Fe3+ delivery to the AM. Ongoing studies using this assay are allowing us to better determine: (1) whether mass (and/or molar) relationships between Fe and V, Al, and/or Mn in any PM2.5 sample consistently govern the extent of change in AM Fe status; (2) how much any specified PM2.5 constituent (metal or nonmetal) contributes to the overall disruption of Fe status found induced by an intact parent sample; and (3) whether induced changes in binding activity are relatable to other changes expected to occur in the AM, that is, in IRP-dependent mRNA/levels of ferritin/transferrin receptor and Fe-dependent functions. These studies demonstrate that pollutant-induced effects on lung cell Fe status can be assessed in a reproducible manner using an assay that can be readily performed by investigators who might otherwise have no access to other very costly analytical equipment, such as graphite atomic absorption or x-ray fluorescence spectro(photo)meters.
Subject(s)
Iron-Regulatory Proteins/metabolism , Iron/metabolism , Macrophages, Alveolar/metabolism , Particulate Matter/metabolism , Air Pollutants/analysis , Air Pollutants/metabolism , Animals , Cell Line , Iron/pharmacology , Macrophages, Alveolar/drug effects , Particulate Matter/analysis , Protein Binding/drug effects , Protein Binding/physiology , RatsABSTRACT
DEC1/STRA13 is a bHLH type transcriptional regulator involved with immune regulation, hypoxia response and carcinogenesis. We recently demonstrated that STRA13 interacts with STAT3 in the transcriptional activation of STAT-dependent promoters. Here, we pursue STRA13 involvement in the JAK/STAT pathway by studying its role in STAT1 expression. First, we showed that VHL deficiency or HIF-1 activation resulted in the repression of endogenous STAT1 mediated by STRA13. We then characterized the STAT1 proximal promoter to assess its response to STRA13 by transient coexpression in a luciferase reporter assay. Using sequential truncation and site-directed mutagenesis of the STAT1 promoter with STRA13 deletion constructs, we showed that the STRA13 C-terminal trans-activation domain, which is known to bind HDAC1, mostly determines the repressive activity. Involvement of HDAC activity in STAT1 regulation was validated by TSA inhibition and chromatin immunoprecipitation (ChIP) assay. Thus, we demonstrate that STRA13-mediated repression of STAT1 transcription utilizes an HDAC1-dependent mechanism. Furthermore, we show that targets of unphosphorylated STAT1, such as antigen presenting genes and CASP1, are also repressed by hypoxia possibly through the same STRA13-mediated mechanism. Thus, the newly discovered link between HIF-1 and STAT1 reveals a previously unknown role of STRA13 in hypoxia and carcinogenesis.
Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Down-Regulation , Homeodomain Proteins/metabolism , Hypoxia-Inducible Factor 1/metabolism , STAT1 Transcription Factor/metabolism , Amino Acid Motifs , Animals , Base Sequence , Cell Hypoxia/genetics , Cell Line , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/metabolism , Gene Expression Regulation, Neoplastic , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Humans , Hypoxia-Inducible Factor 1/deficiency , Hypoxia-Inducible Factor 1/genetics , Mice , Mice, Knockout , Molecular Sequence Data , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-myb/genetics , Proto-Oncogene Proteins c-myb/metabolism , STAT1 Transcription Factor/genetics , Transcription, Genetic/genetics , Transcriptional ActivationABSTRACT
Cap43 is a protein whose RNA is induced under conditions of severe hypoxia or prolonged elevations of intracellular calcium. Cap43 protein is expressed at low levels in normal tissues; however, in a variety of cancers, including lung, brain, melanoma, liver, prostate, breast, and renal cancers, Cap43 protein is overexpressed in cancer cells. The low level of expression of Cap43 in some normal tissues compared to their cancerous counterparts combined with the high stability of Cap43 protein and mRNA makes the Cap43 gene a new, important cancer marker. We hypothesize that the mechanism of Cap43 overexpression in cancer cells involves a state of hypoxia characteristic of cancer cells where the Cap43 protein becomes a signature for this hypoxic state.
Subject(s)
Neoplasm Proteins/metabolism , Neoplasms/diagnosis , Proteins/metabolism , Blotting, Western , Cell Cycle Proteins , Cell Hypoxia , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins , Proteins/genetics , RNA, Messenger/genetics , Tumor Cells, CulturedABSTRACT
Humans are exposed to carcinogenic nickel (Ni) compounds both occupationally and environmentally. In this paper, molecular mechanisms of nickel carcinogenesis are considered from the point-of-view of the uptake of nickel sulfide particles in cells, their dissolution and their effects on heterochromatin. Molecular mechanisms by which nickel induces gene silencing, DNA hypermethylation and inhibition of histone acetylation, will be discussed.
Subject(s)
Carcinogens/adverse effects , Neoplasms/chemically induced , Nickel/adverse effects , Acetylation/drug effects , Animals , Carcinogens/pharmacokinetics , Carcinogens/toxicity , Cell Survival/drug effects , DNA Damage , DNA Fragmentation/drug effects , DNA Methylation/drug effects , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Silencing/drug effects , Histones/metabolism , Humans , Neoplasms/genetics , Neoplasms/metabolism , Nickel/pharmacokinetics , Nickel/toxicityABSTRACT
The increasing utilization of heavy metals in modern industries leads to an increase in the environmental burden. Nickel represents a good example of a metal whose use is widening in modern technologies. As the result of accelerated consumption of nickel-containing products nickel compounds are released to the environment at all stages of production and utilization. Their accumulation in the environment may represent a serious hazard to human health. Among the known health related effects of nickel are skin allergies, lung fibrosis, variable degrees of kidney and cardiovascular system poisoning and stimulation of neoplastic transformation. The mechanism of the latter effect is not known and is the subject of detailed investigation. This review provides an analysis of the current state in the field.
Subject(s)
Nickel/adverse effects , Animals , Body Fluids/chemistry , Calcium/metabolism , Cell Transformation, Neoplastic/chemically induced , Cells, Cultured/drug effects , Cocarcinogenesis , Drug Administration Routes , Environmental Exposure , Female , Homeostasis , Humans , Male , Metalloproteins/chemistry , Mice , Neoplasms/chemistry , Neoplasms, Experimental/chemically induced , Nickel/administration & dosage , Nickel/chemistry , Nickel/metabolism , Nickel/pharmacology , Oxidative Stress , Rats , Signal Transduction/drug effects , Species Specificity , Transcription, Genetic/drug effectsABSTRACT
A review of the molecular mechanisms of nickel carcinogenesis has been compiled. This work is based upon approximately 20 years of research conducted in my laboratory. Molecular mechanisms of nickel carcinogenesis are considered from the point-of-view of the uptake of nickel, both soluble and insoluble particles in cells, its dissolution and its effects on heterochromatin. Molecular mechanisms by which nickel induces gene silencing in cells by DNA hypermethylation in mammalian cells and by inhibiting histone acetylation in yeast cells are also discussed.
Subject(s)
Carcinogens/toxicity , Gene Silencing/drug effects , Heterochromatin/genetics , Nickel/toxicity , Animals , Carcinogens/pharmacokinetics , DNA Methylation/drug effects , Humans , Nickel/pharmacokinetics , Phagocytosis/drug effects , Telomere , X Chromosome , YeastsABSTRACT
P-glycoprotein is a cellular efflux pump. The P-glycoprotein inhibitor PSC 833 causes apoptosis of cancer cells and induces a rise in the intracellular levels of ceramide. Our aims were to determine whether a cause and effect relationship exists between these two actions of PSC 833, and to assess whether the PSC 833-induced apoptosis is restricted to transformed cells. Apoptosis was determined by flow cytometry and radioactive quantitation of DNA fragmentation. PSC 833 induced apoptosis in the human T leukemia cell lines: Molt-4 and Jurkat. Analysis of the apoptosis in Molt-4 and Jurkat cells revealed that PSC 833 induced a rise in the cellular ceramide levels (as measured by the DG kinase assay). PSC 833-induced apoptosis was significantly reduced by specific inhibitors of ceramide de novo synthesis (i.e., fumonisin B1 and L-cycloserine). On the other hand, PSC 833 did not induce apoptosis in normal peripheral blood T cells regardless of whether these cells were quiescent, activated, or proliferating. Our results suggest that PSC 833 induces apoptotic death in human transformed T lymphocytes through an increase in ceramide de novo synthesis. In addition, normal lymphocytes are not susceptible to induction of apoptosis by PSC 833. This difference between normal lymphocytes and leukemia cells presents a potential target for chemotherapy.
Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cyclosporins/pharmacology , Leukemia, T-Cell/drug therapy , Cell Line, Transformed , Ceramides/biosynthesis , Cycloserine/pharmacology , DNA Fragmentation , DNA, Neoplasm/analysis , Diacylglycerol Kinase/analysis , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Drug Screening Assays, Antitumor , Flow Cytometry , Humans , Jurkat Cells , Leukemia, T-Cell/metabolism , Leukemia, T-Cell/pathology , T-Lymphocytes/drug effects , Tumor Cells, CulturedABSTRACT
The tetradecapeptide containing the 10 aminoacid repeated sequence on the C-terminus of the Ni(II)-induced Cap43 protein, was analyzed for Ni(II) and Cu(II) binding. A combined pH-metric and spectroscopic UV-VIS, EPR, CD and NMR study of Ni(II) and Cu(II) binding to the blocked CH3CO-Thr-Arg-Ser-Arg-Ser-His-Thr-Ser-Glu-Gly-Thr-Arg-Ser-Arg-NH2 (Ac-TRSRSHTSEGTRSR-Am) peptide, modeling a part of the C-terminal sequence of the Cap43 protein, revealed the formation of octahedral complexes involving imidazole nitrogen of histidine, at pH 5.5 and pH 7 for Cu(II) and Ni(II), respectively; a major square planar 4N-Ni(II) complex (about 100% at pH 9, log K* = -28.16) involving imidazole nitrogen of histidine and three deprotonated amide nitrogens of the backbone of the peptide was revealed; a 3N-Cu(II) complex (maximum about 70% at pH 7, log K*=-13.91) and a series of 4N-Cu(II) complexes starting at pH 5.5 (maximum about 90% at pH 8.7, log K* = -21.39 for CuH(-3)L), were revealed. This work supports the existence of a metal binding site at the COOH-terminal part of the Cap43 peptide.
Subject(s)
Proteins/chemistry , Proteins/metabolism , Amino Acid Sequence , Binding Sites , Cell Cycle Proteins , Circular Dichroism , Copper/metabolism , Copper/toxicity , In Vitro Techniques , Intracellular Signaling Peptides and Proteins , Magnetic Resonance Spectroscopy , Nickel/metabolism , Nickel/toxicity , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Protein BindingABSTRACT
Hypoxia limits tumor growth but selects for higher metastatic potential. We tested the functional activity of hypoxia-inducible factor-1 (HIF-1) in prostate cell lines ranging from normal epithelial cells (PrEC), hormone-dependent LNCaP, hormone-independent DU145, PC-3 to highly metastatic PC-3M cancer cell lines. We found that HIF-1-stimulated transcription was the lowest in PrEC and LNCaP cells and the highest in PC-3M cells. The induction by hypoxia of the HIF-1 dependent genes Cap43 and GAPDH was the highest in the most aggressive PC-3M cancer cells. Because these advanced prostate cancer cell lines have lost p53 function, this further shifts a balance from p53 to HIF-1 transcriptional regulation, and a high ratio of HIF-1-dependent:p53-dependent transcription was a marker of the advanced malignant phenotype. Transient transfection of HIF-1alpha expression vector induced transcription from p21 promoter construct in prostate cancer cell lines. Furthermore, hypoxia slightly induced p21 mRNA in these cells. However, neither expression of p21 nor hypoxia caused growth arrest in PC-3M cells. Therefore, high inducibility of HIF-1-dependent genes, loss of p53 functions with high ratio of HIF-1-dependent:p53-dependent transcription, and loss of sensitivity to p21 inhibition is a part of hypoxic phenotype associated with aggressive cancer behavior.
Subject(s)
Cyclins/physiology , DNA-Binding Proteins/genetics , Nuclear Proteins/genetics , Prostatic Neoplasms/genetics , Transcription Factors/genetics , Tumor Suppressor Protein p53/physiology , Cell Cycle/genetics , Cell Cycle Proteins , Cell Hypoxia/genetics , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/biosynthesis , Cyclins/genetics , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/physiology , Flow Cytometry , Gene Expression Regulation, Neoplastic , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Humans , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Intracellular Signaling Peptides and Proteins , Male , Neoplasm Metastasis , Nuclear Proteins/biosynthesis , Nuclear Proteins/physiology , Promoter Regions, Genetic/genetics , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Protein Biosynthesis , Proteins/genetics , Transcription Factors/biosynthesis , Transcription Factors/physiology , Transcription, Genetic/physiology , Transcriptional Activation/genetics , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/geneticsABSTRACT
This article considers the mechanism of nickel carcinogenesis, focusing primarily on the epigenetic changes associated with exposure of cells to carcinogenic nickel compounds. We discuss the delivery of nickel in the cell and contrast the genetic and epigenetic changes that have occurred. Within the epigenetic effects, alteration in the levels of transcription factors, such as ATF-1, p53, HIF-1, HIF-1alpha, and NFkappaB, are considered. The relationship between nickel and calcium metabolism and the role it plays in nickel carcinogenesis is also considered, as are reactive oxygen species and the interactions of nickel with proteins. We discuss these epigenetic discussions in light of the effects that nickel has on inducing DNA methylation in cells. It is of interest that nickel induces both a variety of signaling pathways as well as genes that seem to be important for the survival of cancer cells. It is also interesting that the same genes induced or repressed by nickel are similarly overexpressed or not expressed in nickel-transformed cells. It is suggested that this may represent a selection process crucial to the nickel carcinogenesis process.
Subject(s)
Acetyltransferases/metabolism , Carcinogens/toxicity , DNA Methylation/drug effects , Histones/metabolism , Neoplasms/chemically induced , Neoplasms/genetics , Nickel/toxicity , Saccharomyces cerevisiae Proteins , Acetylation/drug effects , Animals , Calcium/metabolism , Genetic Predisposition to Disease , Histone Acetyltransferases , Humans , Neoplasms/metabolism , Transcription Factors/metabolismABSTRACT
Nickel (Ni2+) and cobalt (Co2+) mimic hypoxia and were used as a tool to study the role of oxygen sensing and signaling cascades in the regulation of hypoxia-inducible gene expression. These metals can produce oxidative stress; therefore, it was conceivable that reactive oxygen species (ROS) may trigger signaling pathways resulting in the activation of the hypoxia-inducible factor (HIF)-1 transcription factor and up-regulation of hypoxia-related genes. We found that the exposure of A549 cells to Co2+ or Ni2+ produced oxidative stress, and although Co2+ was a more potent producer of ROS than Ni2+, both metals equally increased the expression of Cap43, a hypoxia-regulated gene. The coadministration of hydrogen peroxide with metals induced more ROS; however, this did not further increase the expression of Cap43 mRNA. The free radical scavenger 2-mercaptoethanol completely suppressed ROS generation by CoCl2 and NiCl2 but did not diminish the induced Cap43 gene expression. The activity of the HIF-1 transcription factor as assessed in transient transfection assays was stimulated by Ni2+, hypoxia, and desferrioxamine, but this activation was not diminished when oxidative stress was attenuated nor was HIF-dependent transcription enhanced by hydrogen peroxide. We conclude that ROS are produced during the exposure of cells to metals that mimic hypoxia, but the formation of ROS was not involved in the activation of HIF-1-dependent genes.
Subject(s)
Carcinogens/toxicity , Cell Hypoxia/physiology , Cobalt/toxicity , DNA-Binding Proteins/metabolism , Nickel/toxicity , Nuclear Proteins/metabolism , Proteins/genetics , Transcription, Genetic/drug effects , Cell Cycle Proteins , Endothelium, Vascular , Free Radical Scavengers/pharmacology , Gene Expression Regulation, Neoplastic , Humans , Hydrogen Peroxide/toxicity , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Intracellular Signaling Peptides and Proteins , Lung Neoplasms , Mercaptoethanol/pharmacology , Reactive Oxygen Species/physiology , Transcription Factors/metabolism , Transcription, Genetic/physiology , Tumor Cells, CulturedABSTRACT
Chromatin proteins are believed to represent reactive sites for nickel binding. The unique structure of the N-terminal tail of histone H4 contains sites for post-translational modification close to a histidine residue capable of anchoring binding sites for metal ions. We have analyzed as a minimal model for the H4 tail, the blocked peptide CH(3)CO-AKRHRK-CONH(2) for nickel and copper binding. Ultraviolet-visible, circular dichroism, electron paramagnetic resonance and nuclear magnetic resonance spectroscopic analysis showed that histidine acts as an anchoring metal binding site. A 1N complex is formed between pH=5-7 and 4-6 for Ni(II) and Cu(II), respectively, while at a higher pH a series of 4N complexes are formed. Above pH 8, the 2N high-spin octahedral resulted in a 4N low-spin planar Ni(II) complex. The stability constants of the Cu(II) (3N, 4N) and Ni(II) (4N) complexes with the peptide model of the H4 were distinctly higher than those for a similar blocked peptide with a histidine in the fourth position. Significant shifts in the alphaproton region in the 1H NMR spectrum of the 4N Ni-complex showed that the conformation of the peptide had been dramatically affected following Ni(II) complexation.
Subject(s)
Copper/chemistry , Histones/chemistry , Nickel/chemistry , Amino Acid Sequence , Binding Sites , Magnetic Resonance Spectroscopy , Organometallic Compounds/chemistry , Peptide Fragments/chemistry , PotentiometryABSTRACT
Environmental factors influence carcinogenesis by interfering with a variety of cellular targets. Carcinogenic nickel compounds, although generally inactive in most gene mutation assays, induce chromosomal damage in heterochromatic regions and cause silencing of reporter genes when they are located near telomere or heterochromatin in either yeast or mammalian cells. We studied the effects of nickel on the lysine acetylation status of the NH2-terminal region of histone H4. At nontoxic levels, nickel decreased the levels of histone H4 acetylation in vivo in both yeast and mammalian cells, affecting only lysine 12 in mammalian cells and all of the four lysine residues in yeast. In yeast, lysine 12 and 16 were more greatly affected than lysine 5 and 8. Interestingly, a histidine Ni2+ anchoring site is found at position 18 from the NH2-terminal tail of H4. Nickel was also found to inhibit the acetylation of H4 in vitro using purified recombinant histone acetyltransferase. To our knowledge, this is the first agent shown to decrease histone H4 acetylation at nontoxic levels.
Subject(s)
Acetyltransferases/antagonists & inhibitors , Histones/metabolism , Nickel/pharmacology , Saccharomyces cerevisiae Proteins , Acetylation , Cadmium Chloride/pharmacology , Copper Sulfate/pharmacology , Histidine , Histone Acetyltransferases , Histones/chemistry , Histones/isolation & purification , Humans , Lung Neoplasms , Saccharomyces cerevisiae/metabolism , Tumor Cells, CulturedABSTRACT
Carcinogenic nickel compounds alter the program of gene expression in normal cells and induce a pattern of gene expression similar to that found in nickel-induced cancers. Here we have demonstrated that nickel exposure induced hypoxic signaling pathways by inducing hypoxia-inducible transcription factor-1 (HIF-1), which mediated the induction of genes required by cells to survive hypoxia. We also show that a new gene, Cap43, is dependent upon HIF-1 because only HIF-1-proficient cells induced Cap43 when exposed to either hypoxia or nickel. We also show that glyceraldehyde-3-phosphate dehydrogenase, a gene induced by hypoxia through HIF-1, was similar to Cap43 in that it required HIF-1-proficient cells to be induced by either nickel or hypoxia. These data demonstrate that nickel exposure turns on signaling for hypoxic stress, which may be important in its carcinogenesis.
Subject(s)
Carcinogens/toxicity , Cell Hypoxia/genetics , DNA-Binding Proteins/physiology , Gene Expression/drug effects , Nickel/toxicity , Nuclear Proteins/physiology , Proteins/drug effects , Transcription Factors , Animals , Blotting, Northern , Blotting, Western , Calcium/metabolism , Cell Cycle Proteins , Cell Hypoxia/physiology , DNA-Binding Proteins/genetics , Fibroblasts/metabolism , Humans , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Intracellular Signaling Peptides and Proteins , Ionophores/pharmacology , Mice , Mice, Knockout , Nuclear Proteins/genetics , Proteins/metabolism , RNA Processing, Post-Transcriptional , RNA, Messenger/metabolism , Signal Transduction/drug effects , Tumor Cells, CulturedABSTRACT
We have recently cloned a gene, Cap43, that was significantly induced by exposure to nontoxic levels of both water-soluble and -insoluble Ni(2+) compounds. In this paper, we utilized the expression levels of this gene as a tool to identify second messengers involved in nickel-inducible transcription. We report here that the Ca(2+) ionophore A23187 substantially stimulated Cap43 gene expression. In addition, we found that BAPTA-AM, a specific chelator of free intracellular Ca(2+), consistently attenuated the induction of Cap43, indicating that elevation of intracellular Ca(2+) was essential for this response. TPEN, a chelator of heavy metals, such as Ni(2+) with a very low affinity for Ca(2+), did not attenuate Cap43 induced by Ni or calcium ionophore, suggesting that elevations of Ca(2+) but probably not elevations of other metal ions were involved in the induction of Cap43. A direct measurement of Ca(2+) levels using the fluorescent probe Fluo-3 AM showed elevations of free intracellular Ca(2+) in Ni-treated cells. A strong induction of Cap43 by okadaic acid suggested the involvement of a serine/threonine phosphorylation in a signaling pathway that was presumably activated by Ni and that led to enhanced Cap43 gene expression. However, calcium-dependent protein kinase(s) involved in the nickel-activated signaling pathway remains to be identified.
Subject(s)
Calcium Channel Blockers/pharmacology , Calcium/metabolism , Gene Expression Regulation/drug effects , Nickel/pharmacology , Protein Biosynthesis , Calcium/analysis , Cell Cycle Proteins , Cell Line , Cells, Cultured , Endothelium, Vascular/drug effects , Homocysteine/pharmacology , Humans , Intracellular Signaling Peptides and Proteins , Phosphorylation , Proteins/geneticsABSTRACT
Nickel (Ni) compounds are potent carcinogens and can induce malignant transformation of rodent and human cells. In an attempt to unravel the molecular mechanisms of Ni-induced transformation we investigated transcriptional activity of hypoxia-inducible factor (HIF-1) and p53 tumor suppressor protein in Ni-transformed cells. We demonstrated that the activity of HIF-1-responsive promoters was increased in Ni-transformed rodent cells resulting in the increased ratio between HIF-1- and p53-stimulated transcription. To further elucidate the roles of HIF-1 and p53 in Ni-induced transformation we used human osteosarcoma (HOS) cells and a Ni-transformed derivative, SA-8 cells. Since non-functional p53 was expressed in both HOS and SA-8 cells, acute Ni treatment induced HIF-1alpha protein and HIF-1-dependent transcription without affecting p53. In MCF-7 and A549, human cancer cells with the wild-type p53, both functional p53 and HIF-1alpha proteins accumulated following exposure to Ni. The induction of HIF-1alpha and wild-type p53 by Ni was detected after 6 h and was most pronounced by 24 h. These results suggest that acute Ni treatment causes accumulation of HIF-1alpha protein and simultaneous accumulation of wild-type, but not mutant, p53. We suggest that the induction of hypoxia-like conditions in Ni-treated cells with subsequent selection for increased HIF-1-dependent transcription is involved in Ni-induced carcinogenesis.
Subject(s)
Carcinogens, Environmental/toxicity , Cell Transformation, Neoplastic/drug effects , DNA-Binding Proteins/metabolism , Gene Expression Regulation/drug effects , Nickel/toxicity , Nuclear Proteins/metabolism , Transcription Factors , Transcription, Genetic/drug effects , Tumor Suppressor Protein p53/metabolism , 3T3 Cells/drug effects , Adenocarcinoma/pathology , Animals , Bone Neoplasms/pathology , Breast Neoplasms/pathology , Bronchi/cytology , Cadmium Chloride/toxicity , Cell Hypoxia , Cobalt/toxicity , Cricetinae , Cricetulus , Epithelial Cells/drug effects , Fibroblasts/drug effects , Genes, p53 , Humans , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Lung Neoplasms/pathology , Mice , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Osteosarcoma/pathology , Promoter Regions, Genetic , Recombinant Fusion Proteins/metabolism , Tumor Cells, CulturedABSTRACT
Effects of oxidative stress on stimulation-dependent signal transduction, leading to IL-2 expression, were studied. Purified quiescent human blood T lymphocytes were subjected to: (i) acute exposure to hydrogen peroxide; (ii) chronic exposure to hydrogen peroxide; and (iii) acute exposure to ionizing radiation. The cells were then stimulated for 6 h. DNA-binding activities (determined by the electrophoretic mobility shift assay) of three transcription factors: NFkappaB, AP-1 and NFAT, were abolished in the lymphocytes by all three modes of oxidative stress. The lymphocytes exhibited lipid peroxidation only upon exposure to the lowest level of hydrogen peroxide used (20 microM). All three modes of oxidative stress induced catalase activity in the lymphocytes. The only exception was hydrogen peroxide at 20 microM, which did not induce catalase activity. We conclude that: (i) suppression of specific transcription factor functions can potentially serve as a marker of exposure to oxidative stress and its effects on human lymphocytes; (ii) lipid peroxidation is only detectable in human lymphocytes upon exposure to weak oxidative stress which does not induce catalase activity; (iii) therefore, transcription factor DNA-binding activities are more sensitive to oxidative stress than lipid peroxidation.
Subject(s)
Lymphocytes/metabolism , Nuclear Proteins , Oxidative Stress , Transcription Factors/metabolism , Catalase , Cells, Cultured , DNA/metabolism , DNA-Binding Proteins/metabolism , Humans , Hydrogen Peroxide/metabolism , Hydroxyl Radical/metabolism , Lipid Peroxides/metabolism , Lymphocyte Activation , Lymphocytes/radiation effects , Monoamine Oxidase/metabolism , NF-kappa B/metabolism , NFATC Transcription Factors , Oxidative Stress/genetics , Oxidative Stress/immunology , Transcription Factor AP-1/metabolismABSTRACT
To better understand the molecular mechanism(s) involved in the essentiality, toxicity, and/or carcinogenicity of nickel compounds, a mRNA differential display technique was used to identify gene(s) that were specifically induced by these carcinogens. Differential expression of several genes was observed in human lung A549 cells exposed to nickel subsulfide. One gene, Cap43, which expressed a 3.0-kb mRNA encoding a Mr 43,000 protein, was found to be induced within 4-6 h by either Ni3S2 or NiCl2 in A549 cells and attained a level as high as 30-fold within 24-36 h of treatment. Twelve other tested metal compounds failed to induce Cap43 expression, leading to the conclusion that, with regard to metals, the induction of this gene was nickel-specific. Oxidative stress that is often caused by metals and heat shock did not induce Cap43 further, suggesting a specific nature in the signaling pathway involved in Cap43 induction. Activation of signaling pathways with vanadate did not induce Cap43 nor did trifluoperazine block its induction by nickel; however, okadaic acid, a serine/threonine phosphatase inhibitor, induced Cap43 to a greater extent than any nickel compound tested. Homocysteine did not induce Cap43 in a number of cell lines, with the exception of human endothelial cells. The Cap43 gene was found to be induced by nickel not only in all tested human and rodent cell lines in vitro but also in several rat organs after oral exposure to NiCl2. We have found that the primary signal for Cap43 induction was an elevation of free intracellular Ca2+ caused by Ni2+ exposure because Cap43 was induced by calcium ionophores and its induction was attenuated by bis-(O-aminophenyl)-ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl)-ester, a chelator of intracellular Ca2+. We found that the Cap43 gene was evolutionarily conserved and similarly regulated in humans, mice, and rats. Recent studies have shown that Cap43 is expressed at lower levels in colon cancer. Further studies of Cap43 regulation by Ca2+ should enhance our understanding of the role of Cap43 in cell function and cancer pathogenesis.
Subject(s)
Gene Expression Regulation/drug effects , Nickel/pharmacology , Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Cycle Proteins , Cells, Cultured/drug effects , Cloning, Molecular , Female , Humans , Intracellular Signaling Peptides and Proteins , Lung/drug effects , Male , Mice , Molecular Sequence Data , Proteins/chemistry , Proteins/drug effects , Rats , Rats, Sprague-Dawley , Sequence Alignment , Sequence Homology, Amino AcidABSTRACT
Thrombospondin I (TSP I) is an extracellular matrix glycoprotein that influences cell adhesion, motility, and growth. On the basis of its effects on endothelial cell proliferation, TSP I has attracted interest as a potential regulator of solid tumor growth through modulation of tumor blood supply. The regulation of TSP I expression is of critical importance for designing new approaches in tumor therapy. Recently, we have shown that TSP I expression is lost in nickel-transformed cells. In this paper, we identified an activating transcription factor (ATF)/cAMP-responsive element-binding protein binding site as a negative regulatory site in the 5'-flanking sequence of mouse TSP I promoter. We identified ATF-1 as a major component of the ATF/cAMP-responsive element-binding protein binding complex. This Mr 35,000 nuclear ATF-1 protein was shown to be present in higher amounts in nickel-transformed 3T3 cells that do not express TSP 1. Acute treatment of 3T3 cells with NiCl2 resulted in the induction of this transcription factor, and this induction was correlated temporally with the suppression of TSP I expression in the same cells. These results show that nickel exposure causes accumulation of the ATF-1 transcription factor, which is responsible for the down-regulation of transcription of TSP I, and possibly other tumor suppressor genes during nickel-induced cellular transformation.
Subject(s)
DNA-Binding Proteins , Nickel/pharmacology , Thrombospondin 1/genetics , Transcription Factors/drug effects , 3T3 Cells , Activating Transcription Factor 1 , Animals , Binding Sites , Cells, Cultured , Gene Expression/drug effects , Genes, Reporter , Genetic Vectors/genetics , Methylation , Mice , Polymerase Chain Reaction , Promoter Regions, Genetic , Thrombospondin 1/metabolism , Transcription Factors/physiology , Transcription, Genetic/drug effects , TransfectionABSTRACT
alpha-Latrotoxin is a potent stimulator of neurosecretion. Its action requires extracellular binding to high affinity presynaptic receptors. Neurexin I alpha was previously described as a high affinity alpha-latrotoxin receptor that binds the toxin only in the presence of calcium ions. Therefore, the interaction of alpha-latrotoxin with neurexin I alpha cannot explain how alpha-latrotoxin stimulates neurotransmitter release in the absence of calcium. We describe molecular cloning and functional expression of the calcium-independent receptor of alpha-latrotoxin (CIRL), which is a second high affinity alpha-latrotoxin receptor that may be the major mediator of alpha-latrotoxin's effects. CIRL appears to be a novel orphan G-protein-coupled receptor, a member of the secretin receptor family. In contrast with other known serpentine receptors, CIRL has two subunits of the 120 and 85 kDa that are the result of endogenous proteolytic cleavage of a precursor polypeptide. CIRL is found in brain where it is enriched in the striatum and cortex. Expression of CIRL in chromaffin cells increases the sensitivity of the cells to the effects of alpha-latrotoxin, demonstrating that this protein is functional in coupling to secretion. Syntaxin, a component of the fusion complex, copurifies with CIRL on an alpha-latrotoxin affinity column and forms stable complexes with this receptor in vitro. Interaction of CIRL with a specific presynaptic neurotoxin and with a component of the docking-fusion machinery suggests its role in regulation of neurosecretion.